Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1498
| Despition | LIN7A Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1119 | CD56 Blocking Peptide (AC1119) | 250 µg | inquiry |
| ACPP-1021 | Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021) | 50 µg | inquiry |
| ACPP-1124 | Recombinant Human MAP2C Protein (AC1124) | 25 µl | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1100 | Synthetic Membrane Nanoparticle Human Somatostatin Receptor 2 Protein (AC1100) | 50 µg | inquiry |
| ACPP-1637 | Human NRN1 Protein, His (AC1637) | 2 µg | inquiry |
| ACPP-1484 | Human CPE Protein (AC1484) | 5 µg | inquiry |
| ACPP-1004 | Synthetic Nanodisc Human GPCR GPR20 Protein (AC1004) | 10 µg | inquiry |
| ACPP-1095 | Synthetic Nanodisc Human MLC1 Protein (AC1095) | 10 µg | inquiry |
| ACPP-1010 | Synthetic Nanodisc Human GPR56 Protein (AC1010) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.